SG11201802091RA - Fungal keratitis prophylactic or therapeutic agent - Google Patents
Fungal keratitis prophylactic or therapeutic agentInfo
- Publication number
- SG11201802091RA SG11201802091RA SG11201802091RA SG11201802091RA SG11201802091RA SG 11201802091R A SG11201802091R A SG 11201802091RA SG 11201802091R A SG11201802091R A SG 11201802091RA SG 11201802091R A SG11201802091R A SG 11201802091RA SG 11201802091R A SG11201802091R A SG 11201802091RA
- Authority
- SG
- Singapore
- Prior art keywords
- prophylactic
- therapeutic agent
- fungal keratitis
- keratitis
- fungal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562220847P | 2015-09-18 | 2015-09-18 | |
| PCT/JP2016/077014 WO2017047597A1 (ja) | 2015-09-18 | 2016-09-13 | 角膜真菌症の予防または治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201802091RA true SG11201802091RA (en) | 2018-04-27 |
Family
ID=58288799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201802091RA SG11201802091RA (en) | 2015-09-18 | 2016-09-13 | Fungal keratitis prophylactic or therapeutic agent |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10166217B2 (zh) |
| EP (1) | EP3351244A4 (zh) |
| JP (1) | JP6639364B2 (zh) |
| KR (1) | KR20180053340A (zh) |
| CN (1) | CN108025000A (zh) |
| BR (1) | BR112018005305A2 (zh) |
| HK (2) | HK1253545A1 (zh) |
| MX (1) | MX2018003381A (zh) |
| MY (1) | MY183906A (zh) |
| PH (1) | PH12018500579A1 (zh) |
| SG (1) | SG11201802091RA (zh) |
| TW (1) | TWI721015B (zh) |
| WO (1) | WO2017047597A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112957321B (zh) * | 2021-03-04 | 2022-08-05 | 青岛大学附属医院 | 一种氧化硫酸软骨素改性的那他霉素滴眼液及其制备方法 |
| CN114568490B (zh) * | 2022-04-01 | 2023-12-19 | 眉山职业技术学院(眉山技师学院) | 雷帕霉素在抑制柑橘青霉菌生长中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0608152A2 (pt) | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
| CN101137369A (zh) * | 2005-02-09 | 2008-03-05 | 马库赛特公司 | 用于眼治疗的制剂 |
| WO2007112052A2 (en) | 2006-03-23 | 2007-10-04 | Macusight, Inc. | Formulations and methods for vascular permeability-related diseases or conditions |
| EP2187743B1 (en) * | 2007-08-16 | 2014-07-30 | Santen Pharmaceutical Co., Ltd | Rapamycin formulations for treatment of age related macular degeneration |
-
2016
- 2016-09-13 EP EP16846468.3A patent/EP3351244A4/en not_active Withdrawn
- 2016-09-13 US US15/760,210 patent/US10166217B2/en active Active
- 2016-09-13 BR BR112018005305-8A patent/BR112018005305A2/pt not_active Application Discontinuation
- 2016-09-13 CN CN201680054195.5A patent/CN108025000A/zh active Pending
- 2016-09-13 MY MYPI2018000383A patent/MY183906A/en unknown
- 2016-09-13 SG SG11201802091RA patent/SG11201802091RA/en unknown
- 2016-09-13 TW TW105129822A patent/TWI721015B/zh active
- 2016-09-13 MX MX2018003381A patent/MX2018003381A/es unknown
- 2016-09-13 KR KR1020187010106A patent/KR20180053340A/ko not_active Application Discontinuation
- 2016-09-13 WO PCT/JP2016/077014 patent/WO2017047597A1/ja active Application Filing
- 2016-09-13 JP JP2016178997A patent/JP6639364B2/ja active Active
-
2018
- 2018-03-16 PH PH12018500579A patent/PH12018500579A1/en unknown
- 2018-10-08 HK HK18112748.0A patent/HK1253545A1/zh unknown
- 2018-12-14 HK HK18116109.4A patent/HK1256969A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6639364B2 (ja) | 2020-02-05 |
| CN108025000A (zh) | 2018-05-11 |
| JP2017057199A (ja) | 2017-03-23 |
| BR112018005305A2 (pt) | 2018-10-09 |
| MY183906A (en) | 2021-03-17 |
| US20180271841A1 (en) | 2018-09-27 |
| TW201717943A (zh) | 2017-06-01 |
| PH12018500579A1 (en) | 2018-09-10 |
| WO2017047597A1 (ja) | 2017-03-23 |
| HK1256969A1 (zh) | 2019-10-04 |
| EP3351244A1 (en) | 2018-07-25 |
| TWI721015B (zh) | 2021-03-11 |
| HK1253545A1 (zh) | 2019-06-21 |
| US10166217B2 (en) | 2019-01-01 |
| MX2018003381A (es) | 2018-08-15 |
| EP3351244A4 (en) | 2019-05-01 |
| KR20180053340A (ko) | 2018-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201607550D0 (en) | Ride-sharing range contours | |
| IL255270A0 (en) | exoskeleton | |
| HK1252645A1 (zh) | 按摩機 | |
| HK1258690A1 (zh) | 食品改良劑 | |
| GB201509919D0 (en) | Coating | |
| HUE045330T2 (hu) | Légnyomó szivattyú | |
| AU201813556S (en) | Fender | |
| ZA201801891B (en) | Blasting agent | |
| PL3481933T3 (pl) | Środek zapobiegający szarzeniu | |
| SG10202107298RA (en) | Hair-growth agent | |
| GB2546811B (en) | Frustum rendering | |
| GB201514938D0 (en) | Braring calculation | |
| PL3285606T3 (pl) | Ochrona ciała | |
| IL256195A (en) | Coating | |
| GB201509885D0 (en) | Therapeutic agents | |
| HK1254202A1 (zh) | 三唑衍生物 | |
| HK1256969A1 (zh) | 真菌性角膜炎的預防或治療劑 | |
| GB201714777D0 (en) | Agent | |
| GB2547792B (en) | Retractors | |
| GB201620641D0 (en) | Agent | |
| GB201601431D0 (en) | Pyrrolobenzodiazepines | |
| GB2546366B (en) | Software protection | |
| RS60962B1 (sr) | Zaštita softvera | |
| GB201519631D0 (en) | Sprays | |
| GB2579155B (en) | Frustum rendering |